CA2295474A1 - 123 human secreted proteins - Google Patents
123 human secreted proteins Download PDFInfo
- Publication number
- CA2295474A1 CA2295474A1 CA002295474A CA2295474A CA2295474A1 CA 2295474 A1 CA2295474 A1 CA 2295474A1 CA 002295474 A CA002295474 A CA 002295474A CA 2295474 A CA2295474 A CA 2295474A CA 2295474 A1 CA2295474 A1 CA 2295474A1
- Authority
- CA
- Canada
- Prior art keywords
- seq
- gene
- tissues
- polynucleotides
- polypeptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Computational Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Gastroenterology & Hepatology (AREA)
Applications Claiming Priority (65)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5191897P | 1997-07-08 | 1997-07-08 | |
| US5192997P | 1997-07-08 | 1997-07-08 | |
| US5193297P | 1997-07-08 | 1997-07-08 | |
| US5273297P | 1997-07-08 | 1997-07-08 | |
| US5192697P | 1997-07-08 | 1997-07-08 | |
| US5192597P | 1997-07-08 | 1997-07-08 | |
| US5191697P | 1997-07-08 | 1997-07-08 | |
| US5279597P | 1997-07-08 | 1997-07-08 | |
| US5191997P | 1997-07-08 | 1997-07-08 | |
| US5280397P | 1997-07-08 | 1997-07-08 | |
| US5279397P | 1997-07-08 | 1997-07-08 | |
| US5193197P | 1997-07-08 | 1997-07-08 | |
| US5273397P | 1997-07-08 | 1997-07-08 | |
| US5192097P | 1997-07-08 | 1997-07-08 | |
| US5193097P | 1997-07-08 | 1997-07-08 | |
| US5192897P | 1997-07-08 | 1997-07-08 | |
| US60/051,918 | 1997-07-08 | ||
| US60/051,932 | 1997-07-08 | ||
| US60/052,733 | 1997-07-08 | ||
| US60/051,925 | 1997-07-08 | ||
| US60/052,803 | 1997-07-08 | ||
| US60/052,793 | 1997-07-08 | ||
| US60/051,920 | 1997-07-08 | ||
| US60/051,916 | 1997-07-08 | ||
| US60/051,928 | 1997-07-08 | ||
| US60/051,926 | 1997-07-08 | ||
| US60/051,931 | 1997-07-08 | ||
| US60/051,929 | 1997-07-08 | ||
| US60/051,930 | 1997-07-08 | ||
| US60/052,732 | 1997-07-08 | ||
| US60/052,795 | 1997-07-08 | ||
| US5636097P | 1997-08-18 | 1997-08-18 | |
| US5594797P | 1997-08-18 | 1997-08-18 | |
| US5568497P | 1997-08-18 | 1997-08-18 | |
| US5595497P | 1997-08-18 | 1997-08-18 | |
| US5598497P | 1997-08-18 | 1997-08-18 | |
| US5595097P | 1997-08-18 | 1997-08-18 | |
| US5594897P | 1997-08-18 | 1997-08-18 | |
| US5572397P | 1997-08-18 | 1997-08-18 | |
| US5595397P | 1997-08-18 | 1997-08-18 | |
| US5594997P | 1997-08-18 | 1997-08-18 | |
| US5572297P | 1997-08-18 | 1997-08-18 | |
| US5596497P | 1997-08-18 | 1997-08-18 | |
| US60/056,360 | 1997-08-18 | ||
| US60/055,953 | 1997-08-18 | ||
| US60/055,684 | 1997-08-18 | ||
| US60/055,949 | 1997-08-18 | ||
| US60/055,947 | 1997-08-18 | ||
| US60/055,964 | 1997-08-18 | ||
| US60/055,723 | 1997-08-18 | ||
| US60/055,722 | 1997-08-18 | ||
| US60/055,948 | 1997-08-18 | ||
| US60/055,950 | 1997-08-18 | ||
| US60/055,954 | 1997-08-18 | ||
| US5866097P | 1997-09-12 | 1997-09-12 | |
| US5878597P | 1997-09-12 | 1997-09-12 | |
| US5866497P | 1997-09-12 | 1997-09-12 | |
| US5866197P | 1997-09-12 | 1997-09-12 | |
| US60/058,661 | 1997-09-12 | ||
| US60/058,664 | 1997-09-12 | ||
| US60/058,660 | 1997-09-12 | ||
| US60/058,785 | 1997-09-12 | ||
| US60/055,984 | 1997-10-02 | ||
| US60/051,919 | 1997-10-02 | ||
| PCT/US1998/013684 WO1999002546A1 (en) | 1997-07-08 | 1998-07-07 | 123 human secreted proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2295474A1 true CA2295474A1 (en) | 1999-01-21 |
Family
ID=27586903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002295474A Abandoned CA2295474A1 (en) | 1997-07-08 | 1998-07-07 | 123 human secreted proteins |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US6342581B1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1000084A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2002513295A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2295474A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO1999002546A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002513295A (ja) | 1997-07-08 | 2002-05-08 | ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド | 123種類のヒト分泌タンパク質 |
| EP1798286B1 (en) * | 1997-08-01 | 2011-09-07 | Schering Corporation | Mammalian cell membrane proteins and related reagents |
| EP0949332A3 (en) * | 1998-04-01 | 2001-03-28 | Smithkline Beecham Plc | HSSCRG1 polypeptides |
| AU4406699A (en) * | 1998-05-15 | 1999-12-06 | Paul B. Fisher | Differentiation-associated sequences and methods of use therefor |
| US6753154B1 (en) * | 1998-06-26 | 2004-06-22 | The Regents Of The University Of California | Human AZU-1 gene, variants thereof and expressed gene products |
| AU6394399A (en) | 1998-09-18 | 2000-04-10 | Rockefeller University, The | Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses thereof |
| IL142094A0 (en) * | 1998-09-29 | 2002-03-10 | Gamida Cell Ltd | Methods of controlling proliferation and differentiation of stem and progenitor cells |
| AU2757500A (en) * | 1999-02-10 | 2000-08-29 | Human Genome Sciences, Inc. | 33 human secreted proteins |
| US6544946B1 (en) | 1999-02-19 | 2003-04-08 | Zymogenetics, Inc. | Inhibitors for use in hemostasis and immune function |
| AU772103B2 (en) | 1999-02-19 | 2004-04-08 | Zymogenetics Inc. | Inhibitors for use in hemostasis and immune function |
| CA2370821A1 (en) * | 1999-05-01 | 2000-11-09 | Genaera Corporation | Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| AU5159500A (en) * | 1999-05-27 | 2000-12-18 | Zymogenetics Inc. | Adipocyte complement related protein homolog zacrp7 |
| WO2000078802A2 (en) * | 1999-06-23 | 2000-12-28 | Curagen Corporation | Secreted polypeptides and corresponding polynucleotides |
| WO2001034794A1 (en) * | 1999-11-10 | 2001-05-17 | Smithkline Beecham Biologicals S.A. | Casb7434, an antigen over-expressed in colon cancer |
| US20030187199A1 (en) * | 1999-12-17 | 2003-10-02 | Gen Sobue | Novel protein and gene |
| AU2001249150A1 (en) * | 2000-03-10 | 2001-09-24 | Millennium Pharmaceuticals, Inc. | 26934, a novel cytidine deaminase-like molecule and uses thereof |
| US20030096315A1 (en) | 2000-05-03 | 2003-05-22 | Sanders Mitchell C. | Device for detecting bacterial contamination and method of use |
| US20020111302A1 (en) * | 2000-11-30 | 2002-08-15 | Y. Tom Tang | Novel nucleic acids and polypeptides |
| EP1383929A4 (en) * | 2001-04-04 | 2006-06-07 | Neurome Inc | GENES EXPRESSED IN DARMEPITHELIAL CELLS AND PEYERS 'PATCH M-CELLS |
| IL152904A0 (en) * | 2002-01-24 | 2003-06-24 | Gamida Cell Ltd | Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations |
| EP1465982A4 (en) * | 2002-01-25 | 2006-06-07 | Gamida Cell Ltd | PROCESS FOR EXPANSION OF STEM AND PRESERVATIVE CELLS AND EXPANDED CELL POPULATIONS THEREWITH OBTAINED |
| US9017963B2 (en) * | 2002-01-31 | 2015-04-28 | Woundchek Laboratories (Us), Inc. | Method for detecting microorganisms |
| US8076452B2 (en) * | 2002-03-01 | 2011-12-13 | Erdmann Volker A | Streptavidin-binding peptide |
| GB0208925D0 (en) * | 2002-04-12 | 2002-05-29 | Univ Sheffield | Polypeptide |
| ATE441713T1 (de) | 2002-09-27 | 2009-09-15 | Dainippon Sumitomo Pharma Co | Tumorantigenprotein und dessen verwendung |
| EP1585987B1 (en) * | 2003-01-09 | 2009-08-19 | Beth Israel Deaconess Medical Center, Inc. | Use of adiponectin to diagnose malignancy |
| CA2514938A1 (en) * | 2003-01-31 | 2004-10-14 | Ethicon, Inc. | Method for detecting escherichia coli |
| WO2004072268A2 (en) * | 2003-02-12 | 2004-08-26 | Mayo Foundation For Medical Education And Research | Pkhdl1, a homolog of the autosomal recessive kidney disease gene |
| US7312197B2 (en) * | 2003-02-24 | 2007-12-25 | University Of Maryland, Baltimore | Method of modifying glucose activity using polypeptides selectively expressed in fat tissue |
| US20050075543A1 (en) * | 2003-10-03 | 2005-04-07 | Calabrese Charles A. | Method of anonymous medical testing and providing the patient with the test results |
| US8609358B2 (en) * | 2003-11-03 | 2013-12-17 | Systagenix Wound Management (Us), Inc. | Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria |
| WO2005098903A1 (ja) * | 2004-04-08 | 2005-10-20 | Sen Engineering Co., Ltd. | 誘電体バリア放電エキシマ光源 |
| WO2006030442A2 (en) * | 2004-09-16 | 2006-03-23 | Gamida-Cell Ltd. | Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells |
| EP1849474B1 (en) * | 2005-02-15 | 2016-09-07 | Toagosei Co., Ltd. | Antimicrobial peptide and use thereof |
| US8846393B2 (en) | 2005-11-29 | 2014-09-30 | Gamida-Cell Ltd. | Methods of improving stem cell homing and engraftment |
| WO2008042826A2 (en) * | 2006-09-29 | 2008-04-10 | University Of Maryland, Baltimore | Use of omentin 1 and omentin 2 in the diagnosis and treatment of disease |
| WO2008073578A2 (en) | 2006-12-08 | 2008-06-19 | Iowa State University Research Foundation, Inc. | Plant genes involved in nitrate uptake and metabolism |
| NZ601815A (en) * | 2008-03-31 | 2014-10-31 | Genentech Inc | Compositions and methods for treating and diagnosing asthma |
| US8082730B2 (en) * | 2008-05-20 | 2011-12-27 | Caterpillar Inc. | Engine system having particulate reduction device and method |
| JP5606322B2 (ja) | 2008-10-20 | 2014-10-15 | 昇志 佐藤 | 腫瘍抗原ペプチド及びその利用 |
| KR101615420B1 (ko) | 2010-12-16 | 2016-04-26 | 제넨테크, 인크. | Th2 억제에 관한 진단 및 치료 |
| JP6144673B2 (ja) | 2011-06-03 | 2017-06-07 | オフィディオン インコーポレイティド | 血液脳関門を通過して輸送するための組成物及び方法 |
| WO2013121426A1 (en) | 2012-02-13 | 2013-08-22 | Gamida-Cell Ltd. | Culturing of mesenchymal stem cells |
| US9567569B2 (en) | 2012-07-23 | 2017-02-14 | Gamida Cell Ltd. | Methods of culturing and expanding mesenchymal stem cells |
| US9175266B2 (en) | 2012-07-23 | 2015-11-03 | Gamida Cell Ltd. | Enhancement of natural killer (NK) cell proliferation and activity |
| US10295547B2 (en) | 2013-03-14 | 2019-05-21 | University Of Florida Research Foundation, Incorporated | Use and treatment of di-amino acid repeat-containing proteins associated with ALS |
| US10509045B2 (en) | 2015-05-29 | 2019-12-17 | University Of Florida Research Foundation, Incorporated | Methods for diagnosing Huntington's disease |
| US10940161B2 (en) | 2016-04-04 | 2021-03-09 | University Of Florida Research Foundation, Incorporated | Manipulation of EIF3 to modulate repeat associated non-ATG (RAN) translation |
| PL3439682T3 (pl) * | 2016-04-06 | 2025-12-01 | Plant Health Care, Inc. | Peptydy pochodzące od czynnika wywołującego odpowiedź nadwrażliwości i ich stosowanie |
| EP3612190A4 (en) | 2017-04-17 | 2021-01-20 | University of Florida Research Foundation, Incorporated | REGULATION OF RAN TRANSLATION THROUGH PKR AND EIF2A-P WAYS |
| JP2020517259A (ja) | 2017-04-19 | 2020-06-18 | ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム | 操作された抗原受容体を発現する免疫細胞 |
| EP3688020A4 (en) | 2017-09-25 | 2021-07-14 | University of Florida Research Foundation, Incorporated | IMMUNOASSAYS FOR DETECTION OF RAN PROTEINS |
| AU2018342105B2 (en) | 2017-09-26 | 2023-11-16 | University Of Florida Research Foundation, Incorporated | Use of metformin and analogs thereof to reduce ran protein levels in the treatment of neurological disorders |
| WO2019165121A1 (en) | 2018-02-21 | 2019-08-29 | Board Of Regents, The University Of Texas System | Methods for activation and expansion of natural killer cells and uses therof |
| AU2020348916B2 (en) | 2019-09-20 | 2025-12-18 | University Of Florida Research Foundation, Incorporated | Detection of antibodies against RAN proteins from serum and tissue lysates |
| WO2021072187A2 (en) | 2019-10-10 | 2021-04-15 | University Of Florida Research Foundation, Incorporated | Ran proteins as biomarkers in cag/ctg expansion disorders |
| CN114349826B (zh) * | 2022-02-14 | 2023-05-30 | 山东省科学院生物研究所 | 抗菌肽cgs7及其制备方法和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5580753A (en) * | 1989-05-23 | 1996-12-03 | Ludwig Institute For Cancer Research | DNA encoding the human cytokine, interleukin-9 |
| EP0871702B1 (en) * | 1994-12-06 | 2005-05-25 | Immunex Corporation | Cytokine designated lerk-7 |
| US5707829A (en) * | 1995-08-11 | 1998-01-13 | Genetics Institute, Inc. | DNA sequences and secreted proteins encoded thereby |
| JP2002513295A (ja) | 1997-07-08 | 2002-05-08 | ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド | 123種類のヒト分泌タンパク質 |
| ATE338117T1 (de) | 1997-08-01 | 2006-09-15 | Serono Genetics Inst Sa | 5' ests für proteine, die nicht gewebespezifisch sind |
| DE19733389C2 (de) | 1997-08-01 | 1999-08-19 | Deutsches Krebsforsch | Mittel zur Expression und zum Nachweis eines ein HPOL-Epitop und ein Polypeptid enthaltenden Fusionspolypeptids |
| US6416973B1 (en) | 1997-08-01 | 2002-07-09 | Schering Corporation | Nucleic acids encoding mammalian cell membrane protein MDL-1 |
| AU6394399A (en) | 1998-09-18 | 2000-04-10 | Rockefeller University, The | Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses thereof |
| EP1423134A2 (en) | 2001-03-21 | 2004-06-02 | Human Genome Sciences | Human secreted proteins |
-
1998
- 1998-07-07 JP JP50874499A patent/JP2002513295A/ja not_active Withdrawn
- 1998-07-07 EP EP98935509A patent/EP1000084A4/en not_active Withdrawn
- 1998-07-07 CA CA002295474A patent/CA2295474A1/en not_active Abandoned
- 1998-07-07 WO PCT/US1998/013684 patent/WO1999002546A1/en not_active Ceased
-
1999
- 1999-01-08 US US09/227,357 patent/US6342581B1/en not_active Expired - Fee Related
-
2001
- 2001-10-25 US US09/983,802 patent/US7105644B2/en not_active Expired - Fee Related
- 2001-10-30 US US09/984,490 patent/US20030064412A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1000084A4 (en) | 2003-03-26 |
| US20030064412A1 (en) | 2003-04-03 |
| EP1000084A1 (en) | 2000-05-17 |
| US7105644B2 (en) | 2006-09-12 |
| JP2002513295A (ja) | 2002-05-08 |
| WO1999002546A1 (en) | 1999-01-21 |
| US6342581B1 (en) | 2002-01-29 |
| US20030022185A1 (en) | 2003-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7105644B2 (en) | Secreted protein HHTLF25 antibodies | |
| US20050089911A1 (en) | 87 human secreted proteins | |
| US20030225248A1 (en) | 186 human secreted proteins | |
| EP1040117A1 (en) | 110 human secreted proteins | |
| US6525174B1 (en) | Precerebellin-like protein | |
| EP1051426A1 (en) | 67 human secreted proteins | |
| US20050095612A1 (en) | 70 human secreted proteins | |
| CA2291221A1 (en) | 32 human secreted proteins | |
| WO1999047540A1 (en) | 95 human secreted proteins | |
| CA2294526A1 (en) | 86 human secreted proteins | |
| WO1999035158A1 (en) | 36 human secreted proteins | |
| WO1999011293A1 (en) | 50 human secreted proteins | |
| US7053190B2 (en) | Secreted protein HRGDF73 | |
| EP1027430A1 (en) | 64 human secreted proteins | |
| EP1032838A1 (en) | 125 human secreted proteins | |
| US20060188962A1 (en) | 19 human secreted proteins | |
| CA2305690A1 (en) | 53 human secreted proteins | |
| EP1042674A1 (en) | 148 human secreted proteins | |
| CA2298852A1 (en) | 83 human secreted proteins | |
| WO1999010363A1 (en) | 29 human secreted proteins | |
| US20050214844A1 (en) | 86 human secreted proteins | |
| US20070238664A1 (en) | 70 Human Secreted Proteins | |
| EP1557425A2 (en) | 123 human secreted proteins | |
| EP1439189A2 (en) | 86 Human Secreted Proteins | |
| EP1346999A2 (en) | Human secreted protein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |